Zhejiang East Asia Pharmaceutical Co., Ltd. Class ASSE: 605177

Announcement on Adjusting the Use of the R&D Center Construction Project in the Initial Public Offering Fundraising Projects

· Issued by Zhejiang East Asia Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Adjusting the Use of the R&D Center Construction Project in the Initial Public Offering Fundraising Projects

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment